0000898432-24-000011.txt : 20240103 0000898432-24-000011.hdr.sgml : 20240103 20240103163604 ACCESSION NUMBER: 0000898432-24-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240101 FILED AS OF DATE: 20240103 DATE AS OF CHANGE: 20240103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patel Gautam CENTRAL INDEX KEY: 0001738054 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38485 FILM NUMBER: 24507247 MAIL ADDRESS: STREET 1: C/O AMNEAL PHARMACEUTICALS LLC STREET 2: 400 CROSSING BLVD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001723128 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: BUSINESS PHONE: (908) 947-3120 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD STREET 2: 3RD FLOOR CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Atlas Holdings, Inc. DATE OF NAME CHANGE: 20171117 4 1 form4.xml X0508 4 2024-01-01 0001723128 Amneal Pharmaceuticals, Inc. AMRX 0001738054 Patel Gautam C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BLVD BRIDGEWATER NJ 08807 true false Class A Common Stock 2024-01-01 4 J 0 33458067 D 374318 D Class A Common Stock 2024-01-01 4 G 0 1598115 0 A 1972433 D The reporting person previously controlled an entity (the "Trustee") that serves as the sole trustee of certain trusts (the "Trusts") that hold, in the aggregate, 33,458,067 shares of the Class A Common Stock of the issuer. On January 1, 2024, the reporting person sold to a third party all of the issued and outstanding common stock of the Trustee. In connection therewith, the reporting person also resigned from all positions he previously held with the Trustee, effective as of January 1, 2024. As a result of these transactions, the reporting person no longer has beneficial ownership of any of the shares of Class A Common Stock of the issuer held by any trusts of which the Trustee is the sole trustee. The reporting person is a beneficiary of one of the Trusts. Following the execution of the transactions described in the preceding footnote, on January 1, 2024, the reporting person received a distribution from such Trust of 1,598,115 shares of the Class A Common Stock of the issuer. /s/ Gautam Patel 2024-01-03